DEFEROXAMINE MESYLATE

DEFEROXAMINE MESYLATE was reported 2177 times

DEFEROXAMINE MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUNG DISEASE INFECTIVE EXACERBATION 14 0.5185
1 CARDIAC SIDEROSIS 9 0.3333
2 ANEURYSM RECANALISATION 2 0.2500
3 MODEL FOR END STAGE LIVER DISEASE SCORE ABNORMAL 4 0.2222
4 CARDIAC IRON OVERLOAD 5 0.2174
5 INFECTIVE CHONDRITIS 3 0.2143
6 PYTHIUM INSIDIOSUM INFECTION 2 0.2000
7 FUNDOSCOPY ABNORMAL 19 0.1827
8 HEPATIC IRON OVERLOAD 4 0.1739
9 LIVER IRON CONCENTRATION INCREASED 13 0.1605
10 LARYNGITIS FUNGAL 20 0.1550
11 AUTOIMMUNE PANCYTOPENIA 14 0.1538
12 FOETAL HAEMOGLOBIN INCREASED 2 0.1429
13 ERYTHROID SERIES ABNORMAL 2 0.1333
14 THALASSAEMIA BETA 12 0.1237
15 LIVER IRON CONCENTRATION ABNORMAL 2 0.0800
16 HAEMOSIDEROSIS 17 0.0634
17 HEPATIC SIDEROSIS 5 0.0625
18 CATHETER SITE NECROSIS 2 0.0526
19 BRONCHOALVEOLAR LAVAGE 3 0.0492
20 IRON OVERLOAD 50 0.0463
21 NEONATAL MULTI-ORGAN FAILURE 2 0.0400
22 SERUM FERRITIN ABNORMAL 11 0.0344
23 SERUM FERRITIN INCREASED 171 0.0324
24 ENDOLYMPHATIC HYDROPS 2 0.0317
25 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 6 0.0308
26 HYPOCITRATURIA 2 0.0308
27 COSTOVERTEBRAL ANGLE TENDERNESS 5 0.0305
28 LIVER PALPABLE SUBCOSTAL 2 0.0303
29 ASPIRATION BONE MARROW 4 0.0301
30 PARVOVIRUS INFECTION 12 0.0297
31 RETINAL DYSTROPHY 7 0.0294
32 BETA 2 MICROGLOBULIN URINE INCREASED 4 0.0280
33 BLOOD IRON INCREASED 52 0.0277
34 HAEMOCHROMATOSIS 18 0.0195
35 CATHETER SITE OEDEMA 2 0.0183
36 THALASSAEMIA 3 0.0175
37 HEPATIC INFECTION FUNGAL 2 0.0167
38 KERATITIS HERPETIC 2 0.0164
39 ACINETOBACTER TEST POSITIVE 3 0.0155
40 VITAMIN C DEFICIENCY 3 0.0154
41 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 7 0.0153
42 PNEUMOCYSTIS JIROVECII INFECTION 18 0.0151
43 ZYGOMYCOSIS 7 0.0150
44 PHAEHYPHOMYCOSIS 2 0.0149
45 T-LYMPHOCYTE COUNT DECREASED 10 0.0147
46 COAGULATION FACTOR DECREASED 4 0.0147
47 PARVOVIRUS B19 INFECTION 13 0.0145
48 ERYTHROPOIESIS ABNORMAL 4 0.0131
49 MUCORMYCOSIS 33 0.0127
50 BRONCHOSCOPY 3 0.0127
51 MYODESOPSIA 2 0.0126
52 EXTRAMEDULLARY HAEMOPOIESIS 2 0.0125
53 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 3 0.0120
54 PNEUMOPERICARDIUM 2 0.0116
55 RETICULOCYTE COUNT DECREASED 5 0.0116
56 RETINITIS PIGMENTOSA 3 0.0115
57 RETINOGRAM ABNORMAL 3 0.0112
58 CONJUNCTIVAL PALLOR 2 0.0110
59 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 15 0.0106
60 PLASMACYTOSIS 2 0.0105
61 FAILED INDUCTION OF LABOUR 2 0.0103
62 RETINAL DEGENERATION 13 0.0100
63 CD8 LYMPHOCYTES DECREASED 2 0.0100
64 VIRAL HAEMORRHAGIC CYSTITIS 7 0.0098
65 URINE CALCIUM INCREASED 3 0.0095
66 NEUTROPHIL COUNT 2 0.0095
67 RETINAL PIGMENT EPITHELIOPATHY 4 0.0093
68 BODY MASS INDEX DECREASED 4 0.0086
69 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 4 0.0085
70 SICKLE CELL ANAEMIA 5 0.0078
71 MARROW HYPERPLASIA 5 0.0073
72 BLOOD IRON ABNORMAL 7 0.0072
73 ADENOVIRUS INFECTION 20 0.0069
74 TRANSFUSION REACTION 6 0.0068
75 GRAFT VERSUS HOST DISEASE IN SKIN 15 0.0068
76 RETINAL TOXICITY 7 0.0068
77 CARDIAC FUNCTION TEST ABNORMAL 2 0.0067
78 BIOPSY LIVER ABNORMAL 2 0.0067
79 GLYCOSURIA 9 0.0067
80 CYTOMEGALOVIRUS INFECTION REACTIVATION 29 0.0066
81 FOETAL DISTRESS SYNDROME 13 0.0061
82 HYPERCALCIURIA 3 0.0061
83 VENOOCCLUSIVE DISEASE 15 0.0060
84 FUNGAL TEST POSITIVE 2 0.0057
85 BACTERIAL SEPSIS 18 0.0055
86 OCULAR TOXICITY 6 0.0054
87 ALBUMIN URINE PRESENT 2 0.0053
88 RETICULOCYTE COUNT INCREASED 4 0.0049
89 WRIST DEFORMITY 3 0.0049
90 DYSCHROMATOPSIA 4 0.0048
91 EXTRAVASCULAR HAEMOLYSIS 2 0.0047
92 PNEUMONIA NECROTISING 3 0.0046
93 SERUM FERRITIN DECREASED 8 0.0046
94 TRANSPLANT FAILURE 11 0.0045
95 COLOUR BLINDNESS 4 0.0044
96 RETINOPATHY 16 0.0043
97 BIOPSY BONE MARROW 2 0.0043
98 VENOOCCLUSIVE LIVER DISEASE 21 0.0042
99 MACULOPATHY 15 0.0042
100 GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
101 BODY HEIGHT INCREASED 2 0.0041
102 HYPERSPLENISM 2 0.0040
103 DEBRIDEMENT 3 0.0039
104 MYELODYSPLASTIC SYNDROME TRANSFORMATION 2 0.0038
105 FOETAL GROWTH RETARDATION 3 0.0038
106 DRUG CLEARANCE DECREASED 5 0.0038
107 RETINAL PIGMENTATION 3 0.0038
108 OTOTOXICITY 7 0.0038
109 OPTIC NEUROPATHY 8 0.0038
110 BONE MARROW TRANSPLANT 7 0.0037
111 DEAFNESS NEUROSENSORY 12 0.0036
112 INTRAVASCULAR HAEMOLYSIS 2 0.0036
113 RENAL TUBULAR DISORDER 10 0.0036
114 KLEBSIELLA SEPSIS 4 0.0035
115 FANCONI SYNDROME 5 0.0035
116 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
117 IMMUNE THROMBOCYTOPENIA 15 0.0033
118 APLASTIC ANAEMIA 17 0.0033
119 MUCOSAL DISCOLOURATION 2 0.0031
120 STRIDOR 9 0.0031
121 SICKLE CELL ANAEMIA WITH CRISIS 47 0.0030
122 MYELOFIBROSIS 9 0.0030
123 CATHETER RELATED INFECTION 3 0.0030
124 OESOPHAGITIS ULCERATIVE 2 0.0029
125 ASPERGILLUS INFECTION 19 0.0029
126 FUSARIUM INFECTION 2 0.0029
127 PSEUDOMONAL SEPSIS 5 0.0029
128 INJECTION SITE ABSCESS 7 0.0028
129 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
130 HERPES SIMPLEX 18 0.0028
131 RENAL TUBULAR ACIDOSIS 6 0.0027
132 ESCHAR 2 0.0027
133 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
134 METAMORPHOPSIA 5 0.0027
135 LOCAL REACTION 2 0.0027
136 RETINAL DISORDER 7 0.0027
137 AGRANULOCYTOSIS 50 0.0027
138 CATHETER SITE RELATED REACTION 2 0.0027
139 HYPOPARATHYROIDISM 2 0.0026
140 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
141 NIGHT BLINDNESS 4 0.0025
142 CYSTITIS HAEMORRHAGIC 10 0.0025
143 AUTOIMMUNE HEPATITIS 17 0.0024
144 INJECTION SITE INFECTION 8 0.0024
145 NEONATAL HYPOXIA 2 0.0024
146 HYDROTHORAX 2 0.0024
147 HEPATORENAL SYNDROME 4 0.0024
148 GLUCOSE URINE PRESENT 3 0.0024
149 HAEMOLYSIS 18 0.0023
150 SPLENOMEGALY 27 0.0023
151 SPLENIC INFARCTION 4 0.0023
152 ACUTE CHEST SYNDROME 2 0.0023
153 BODY MASS INDEX INCREASED 3 0.0022
154 PNEUMOMEDIASTINUM 4 0.0022
155 CERUMEN IMPACTION 2 0.0022
156 ANEURYSM RUPTURED 2 0.0022
157 BILIRUBIN CONJUGATED INCREASED 5 0.0021
158 HEPATIC CONGESTION 2 0.0021
159 BLOOD ELECTROLYTES DECREASED 3 0.0021
160 HYPERMETROPIA 2 0.0021
161 MYELODYSPLASTIC SYNDROME 30 0.0021
162 APLASIA PURE RED CELL 7 0.0020
163 CYTOMEGALOVIRUS VIRAEMIA 9 0.0020
164 KNEE DEFORMITY 3 0.0020
165 BONE MARROW DISORDER 6 0.0020
166 DRUG EXPOSURE BEFORE PREGNANCY 2 0.0020
167 HEPATOSPLENOMEGALY 5 0.0019
168 MEAN CELL VOLUME DECREASED 3 0.0019
169 CAROTID ARTERIOSCLEROSIS 2 0.0019
170 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
171 BLAST CELL COUNT INCREASED 2 0.0019
172 ATRIAL TACHYCARDIA 4 0.0019
173 LARGE INTESTINAL ULCER 5 0.0018
174 HEPATOMEGALY 18 0.0018
175 ENTEROBACTER INFECTION 3 0.0018
176 CYTOGENETIC ABNORMALITY 2 0.0018
177 SPLEEN DISORDER 3 0.0018
178 NEUROPATHY 3 0.0018
179 BLOOD FIBRINOGEN DECREASED 2 0.0018
180 BLOOD AMYLASE INCREASED 3 0.0018
181 INJECTION SITE OEDEMA 3 0.0017
182 AORTIC THROMBOSIS 2 0.0017
183 DILATATION ATRIAL 2 0.0017
184 JUGULAR VEIN THROMBOSIS 3 0.0017
185 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
186 SUBCUTANEOUS ABSCESS 8 0.0017
187 DYSPLASIA 2 0.0017
188 BREATH SOUNDS ABNORMAL 8 0.0016
189 BLOOD CREATININE DECREASED 5 0.0016
190 BRADYCARDIA NEONATAL 2 0.0016
191 MALLORY-WEISS SYNDROME 2 0.0016
192 ACIDOSIS 12 0.0016
193 HEPATIC NEOPLASM 5 0.0015
194 ASPERGILLOSIS 2 0.0015
195 VENOUS THROMBOSIS 6 0.0015
196 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
197 INTERNATIONAL NORMALISED RATIO DECREASED 6 0.0015
198 NORMAL NEWBORN 8 0.0015
199 AUTOIMMUNE HAEMOLYTIC ANAEMIA 5 0.0015
200 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
201 HEPATIC FIBROSIS 5 0.0015
202 QUADRIPLEGIA 3 0.0015
203 VISUAL ACUITY REDUCED 48 0.0014
204 AUTOIMMUNE DISORDER 14 0.0014
205 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
206 INJECTION SITE INFLAMMATION 7 0.0014
207 BLOOD UREA INCREASED 23 0.0014
208 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
209 THROMBOCYTOSIS 5 0.0014
210 HAEMATOCRIT DECREASED 27 0.0014
211 GASTROINTESTINAL ULCER 3 0.0014
212 INFUSION SITE INDURATION 2 0.0013
213 PNEUMOCYSTIS JIROVECI PNEUMONIA 3 0.0013
214 LYMPHOPENIA 19 0.0013
215 RENAL COLIC 3 0.0013
216 INFECTIOUS PLEURAL EFFUSION 2 0.0013
217 CYTOPENIA 16 0.0013
218 OPTIC NERVE DISORDER 2 0.0012
219 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
220 HAEMOGLOBIN ABNORMAL 8 0.0012
221 BLOOD CREATININE INCREASED 81 0.0012
222 ACUTE LEUKAEMIA 2 0.0012
223 OPTIC ATROPHY 2 0.0012
224 LYMPHOCYTE COUNT INCREASED 4 0.0012
225 HYPOPHOSPHATAEMIA 9 0.0012
226 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
227 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0012
228 HYPERAMMONAEMIA 6 0.0012
229 BLOOD LACTATE DEHYDROGENASE INCREASED 19 0.0012
230 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
231 HAEMOGLOBIN DECREASED 121 0.0012
232 ENTERITIS INFECTIOUS 2 0.0012
233 LACTOSE INTOLERANCE 3 0.0012
234 MEAN CELL VOLUME INCREASED 3 0.0012
235 MULTI-ORGAN FAILURE 20 0.0012
236 CARDIAC MURMUR 10 0.0012
237 ACUTE MYELOID LEUKAEMIA 18 0.0012
238 KIDNEY FIBROSIS 2 0.0012
239 TRANSFUSION 12 0.0011
240 URINE OUTPUT DECREASED 10 0.0011
241 FANCONI SYNDROME ACQUIRED 2 0.0011
242 LUNG INFILTRATION 10 0.0011
243 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
244 PRODUCT SUPPLY ISSUE 8 0.0011
245 CAESAREAN SECTION 13 0.0011
246 APPARENT DEATH 4 0.0011
247 RENAL TRANSPLANT 4 0.0011
248 ESSENTIAL HYPERTENSION 2 0.0011
249 GASTRIC ULCER HAEMORRHAGE 6 0.0011
250 OPPORTUNISTIC INFECTION 2 0.0011
251 PUPILLARY REFLEX IMPAIRED 2 0.0011
252 INTERVERTEBRAL DISCITIS 2 0.0011
253 BLOOD BICARBONATE DECREASED 2 0.0011
254 MYELOPATHY 2 0.0011
255 MECHANICAL VENTILATION 2 0.0011
256 TRANSAMINASES INCREASED 23 0.0010
257 CONCOMITANT DISEASE PROGRESSION 2 0.0010
258 OCCULT BLOOD POSITIVE 2 0.0010
259 URINE ANALYSIS ABNORMAL 3 0.0010
260 POLYNEUROPATHY 12 0.0010
261 DEVICE RELATED SEPSIS 2 0.0010
262 CARDIAC DISCOMFORT 2 0.0010
263 FUNGAL SKIN INFECTION 4 0.0010
264 KLEBSIELLA INFECTION 5 0.0010
265 FIBROSIS 3 0.0010
266 PORTAL HYPERTENSION 3 0.0010
267 POLYCYTHAEMIA 2 0.0010
268 EJECTION FRACTION DECREASED 15 0.0010
269 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
270 MICROCYTIC ANAEMIA 2 0.0010
271 PULMONARY HYPERTENSION 20 0.0010
272 MOUTH HAEMORRHAGE 7 0.0010
273 EOSINOPHILIC PNEUMONIA 3 0.0010
274 DILATATION VENTRICULAR 2 0.0010
275 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
276 HEPATIC NEOPLASM MALIGNANT 2 0.0009
277 BONE MARROW FAILURE 19 0.0009
278 CD4 LYMPHOCYTES DECREASED 2 0.0009
279 INFUSION SITE PAIN 12 0.0009
280 LYMPHOCYTOSIS 2 0.0009
281 BLOOD BILIRUBIN INCREASED 25 0.0009
282 LIVER ABSCESS 3 0.0009
283 PYELONEPHRITIS 8 0.0009
284 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
285 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
286 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
287 NEPHRITIS 3 0.0009
288 NEUTROPHIL COUNT DECREASED 36 0.0009
289 PERIARTHRITIS 2 0.0009
290 PRESCRIBED OVERDOSE 17 0.0009
291 ATRIAL FLUTTER 7 0.0009
292 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
293 PANCREATITIS NECROTISING 2 0.0009
294 APHTHOUS STOMATITIS 2 0.0009
295 HYPERTRANSAMINASAEMIA 6 0.0009
296 THROMBOPHLEBITIS 3 0.0009
297 ESCHERICHIA BACTERAEMIA 2 0.0008
298 DUODENAL ULCER 6 0.0008
299 URINE ODOUR ABNORMAL 5 0.0008
300 PULMONARY INFARCTION 2 0.0008
301 METABOLIC ACIDOSIS 27 0.0008
302 RETINAL HAEMORRHAGE 6 0.0008
303 MACULAR DEGENERATION 10 0.0008
304 PULSE ABNORMAL 2 0.0008
305 TYPE 1 DIABETES MELLITUS 5 0.0008
306 HUMERUS FRACTURE 4 0.0008
307 HEPATIC FAILURE 25 0.0008
308 MONOCYTE COUNT INCREASED 3 0.0008
309 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
310 CARDIOMYOPATHY 12 0.0008
311 STAPHYLOCOCCAL SEPSIS 4 0.0008
312 PROTEIN URINE PRESENT 4 0.0008
313 CHROMATURIA 18 0.0008
314 HAEMODYNAMIC INSTABILITY 6 0.0008
315 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
316 COAGULOPATHY 13 0.0008
317 HEPATIC FUNCTION ABNORMAL 29 0.0008
318 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
319 LIVER DISORDER 34 0.0008
320 PERSONALITY DISORDER 2 0.0008
321 PROTEIN TOTAL INCREASED 2 0.0008
322 ORGAN FAILURE 3 0.0007
323 JAUNDICE 20 0.0007
324 ANAL ABSCESS 4 0.0007
325 NEPHROLITHIASIS 34 0.0007
326 ABDOMINAL RIGIDITY 2 0.0007
327 RED BLOOD CELL COUNT DECREASED 21 0.0007
328 ACUTE HEPATIC FAILURE 10 0.0007
329 HYPERURICAEMIA 3 0.0007
330 DEAFNESS 19 0.0007
331 PHARYNGITIS 9 0.0007
332 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
333 CONGESTIVE CARDIOMYOPATHY 3 0.0007
334 STREPTOCOCCAL INFECTION 4 0.0007
335 LUNG CONSOLIDATION 2 0.0007
336 C-REACTIVE PROTEIN INCREASED 26 0.0007
337 MITRAL VALVE INCOMPETENCE 8 0.0007
338 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
339 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
340 HEPATIC PAIN 3 0.0007
341 INJECTION SITE SCAR 2 0.0007
342 VISUAL DISTURBANCE 4 0.0007
343 BACTERIAL INFECTION 13 0.0007
344 FIBULA FRACTURE 2 0.0007
345 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
346 PROTEINURIA 13 0.0007
347 PLEURISY 4 0.0007
348 PETECHIAE 7 0.0007
349 BLOOD CULTURE POSITIVE 2 0.0007
350 SEPTIC SHOCK 29 0.0007
351 METABOLIC ENCEPHALOPATHY 2 0.0007
352 HYPERCAPNIA 2 0.0007
353 HEPATITIS C 8 0.0007
354 OPTIC NEURITIS 6 0.0007
355 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
356 LIVER FUNCTION TEST ABNORMAL 19 0.0007
357 RETINAL DETACHMENT 6 0.0007
358 CHEST X-RAY ABNORMAL 2 0.0007
359 DEVICE RELATED INFECTION 10 0.0006
360 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
361 CARDIAC FAILURE 52 0.0006
362 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
363 GENERALISED OEDEMA 8 0.0006
364 APHTHOUS ULCER 5 0.0006
365 HEPATIC ENCEPHALOPATHY 6 0.0006
366 LEUKAEMIA 6 0.0006
367 ORTHOPNOEA 2 0.0006
368 HEPATITIS ACUTE 4 0.0006
369 SHOCK HAEMORRHAGIC 5 0.0006
370 PANCYTOPENIA 34 0.0006
371 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
372 INFLAMMATORY MARKER INCREASED 3 0.0006
373 SPINAL COMPRESSION FRACTURE 5 0.0006
374 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
375 TREATMENT NONCOMPLIANCE 33 0.0006
376 PEPTIC ULCER 2 0.0006
377 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
378 CYTOMEGALOVIRUS INFECTION 10 0.0006
379 RENAL IMPAIRMENT 50 0.0006
380 CLOSTRIDIAL INFECTION 2 0.0006
381 CHOLECYSTITIS 7 0.0006
382 PSEUDOMONAS INFECTION 5 0.0006
383 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
384 BLOOD CREATININE ABNORMAL 2 0.0006
385 ENCEPHALITIS 4 0.0006
386 GRANULOMA 2 0.0006
387 AORTIC STENOSIS 2 0.0006
388 VIRAL INFECTION 19 0.0006
389 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
390 BLINDNESS 23 0.0006
391 GRAFT VERSUS HOST DISEASE 4 0.0006
392 GINGIVITIS 3 0.0006
393 PNEUMONITIS 15 0.0006
394 CUTANEOUS VASCULITIS 2 0.0005
395 ASCITES 16 0.0005
396 BLINDNESS TRANSIENT 4 0.0005
397 DRUG-INDUCED LIVER INJURY 17 0.0005
398 MACULAR OEDEMA 3 0.0005
399 SKIN INFECTION 6 0.0005
400 PREMATURE LABOUR 3 0.0005
401 CATHETER SITE INFECTION 2 0.0005
402 FEBRILE NEUTROPENIA 35 0.0005
403 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
404 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
405 PROCEDURAL COMPLICATION 4 0.0005
406 RENAL FAILURE CHRONIC 4 0.0005
407 ENTEROCOLITIS 3 0.0005
408 ATELECTASIS 5 0.0005
409 ELECTROLYTE IMBALANCE 6 0.0005
410 CARDIOPULMONARY FAILURE 2 0.0005
411 EPIGASTRIC DISCOMFORT 2 0.0005
412 LYMPHOCYTE COUNT DECREASED 9 0.0005
413 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
414 PNEUMONIA FUNGAL 2 0.0005
415 BLOOD IRON DECREASED 6 0.0005
416 TRICUSPID VALVE INCOMPETENCE 4 0.0005
417 LOW BIRTH WEIGHT BABY 4 0.0005
418 CEREBRAL ATROPHY 2 0.0005
419 HEARING IMPAIRED 3 0.0005
420 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
421 SKIN REACTION 7 0.0005
422 SWELLING OF EYELID 3 0.0005
423 SEPSIS 53 0.0005
424 PHOTOPSIA 3 0.0005
425 INFUSION SITE ERYTHEMA 4 0.0005
426 AORTIC VALVE INCOMPETENCE 2 0.0005
427 PLATELET COUNT DECREASED 50 0.0005
428 CHOLESTASIS 9 0.0005
429 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
430 PREMATURE BABY 14 0.0005
431 EAR PAIN 9 0.0005
432 HEPATIC LESION 2 0.0005
433 OCULAR ICTERUS 2 0.0005
434 DRUG SPECIFIC ANTIBODY PRESENT 3 0.0005
435 LEUKOPENIA 23 0.0005
436 OESOPHAGITIS 5 0.0005
437 ABDOMINAL ABSCESS 2 0.0005
438 MENINGITIS 3 0.0004
439 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
440 IRON DEFICIENCY 2 0.0004
441 COLITIS ISCHAEMIC 3 0.0004
442 LEUKOCYTOSIS 8 0.0004
443 PALLOR 12 0.0004
444 HAEMOGLOBIN INCREASED 2 0.0004
445 THROMBOCYTOPENIA 49 0.0004
446 ECCHYMOSIS 3 0.0004
447 ISCHAEMIA 2 0.0004
448 NEOPLASM 5 0.0004
449 CHRONIC MYELOID LEUKAEMIA 2 0.0004
450 LOCALISED OEDEMA 2 0.0004
451 NEPHROPATHY 4 0.0004
452 CHOLELITHIASIS 14 0.0004
453 HEPATIC CIRRHOSIS 8 0.0004
454 DIALYSIS 6 0.0004
455 EATING DISORDER 9 0.0004
456 FEAR OF INJECTION 3 0.0004
457 PULSE ABSENT 2 0.0004
458 NEUTROPENIA 57 0.0004
459 PYREXIA 145 0.0004
460 CARDIOGENIC SHOCK 6 0.0004
461 KIDNEY TRANSPLANT REJECTION 2 0.0004
462 GASTROINTESTINAL TOXICITY 2 0.0004
463 VISUAL FIELD DEFECT 3 0.0004
464 FACE OEDEMA 7 0.0004
465 DRUG INTOLERANCE 40 0.0004
466 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
467 ENCEPHALOPATHY 10 0.0004
468 ORGANISING PNEUMONIA 2 0.0004
469 RENAL FAILURE 53 0.0004
470 BLOOD POTASSIUM DECREASED 12 0.0004
471 ANAEMIA 76 0.0004
472 TOXIC SKIN ERUPTION 4 0.0004
473 BLOOD COUNT ABNORMAL 6 0.0004
474 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
475 HYPERTHERMIA 3 0.0004
476 SUBARACHNOID HAEMORRHAGE 4 0.0004
477 BOWEL MOVEMENT IRREGULARITY 3 0.0004
478 PHLEBITIS 2 0.0004
479 EAR DISCOMFORT 4 0.0004
480 CEREBRAL ISCHAEMIA 2 0.0004
481 RENAL DISORDER 18 0.0004
482 TENDERNESS 4 0.0004
483 PULMONARY HAEMORRHAGE 3 0.0004
484 PLATELET COUNT INCREASED 5 0.0004
485 MALABSORPTION 2 0.0004
486 TOOTH INFECTION 5 0.0004
487 PULMONARY CONGESTION 5 0.0004
488 SCRATCH 4 0.0004
489 BLOOD ALBUMIN DECREASED 3 0.0004
490 PHARYNGOLARYNGEAL PAIN 2 0.0004
491 TRANSPLANT REJECTION 3 0.0004
492 RHINITIS 3 0.0004
493 DIABETES MELLITUS 28 0.0004
494 HEPATIC ENZYME INCREASED 25 0.0004
495 INFECTION 53 0.0004
496 ESCHERICHIA INFECTION 3 0.0004
497 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
498 DENTAL CARIES 4 0.0004
499 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
500 MENTAL STATUS CHANGES 10 0.0004
501 NECROSIS 2 0.0004
502 MASS 5 0.0004
503 PULMONARY OEDEMA 16 0.0004
504 ACUTE PULMONARY OEDEMA 2 0.0004
505 CHOLECYSTITIS ACUTE 2 0.0004
506 ANURIA 3 0.0003
507 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
508 RALES 2 0.0003
509 ABDOMINAL PAIN 80 0.0003
510 GASTROENTERITIS 5 0.0003
511 NEUROTOXICITY 6 0.0003
512 HYPERTRIGLYCERIDAEMIA 2 0.0003
513 PURPURA 3 0.0003
514 BACTERAEMIA 4 0.0003
515 FACIAL PAIN 3 0.0003
516 HAEMOLYTIC ANAEMIA 3 0.0003
517 EYE DISORDER 11 0.0003
518 PROTHROMBIN TIME PROLONGED 2 0.0003
519 HEPATITIS B 2 0.0003
520 FOETAL GROWTH RESTRICTION 2 0.0003
521 RETCHING 7 0.0003
522 RESPIRATORY DISTRESS 9 0.0003
523 LIVER INJURY 8 0.0003
524 LARYNGEAL OEDEMA 2 0.0003
525 PIGMENTATION DISORDER 2 0.0003
526 CARDIAC FAILURE CONGESTIVE 26 0.0003
527 FAECES DISCOLOURED 7 0.0003
528 ILEUS 4 0.0003
529 DYSPNOEA EXERTIONAL 12 0.0003
530 INFUSION SITE SWELLING 2 0.0003
531 GASTRIC ULCER 6 0.0003
532 RESPIRATORY FAILURE 23 0.0003
533 PNEUMOTHORAX 5 0.0003
534 ABSCESS 5 0.0003
535 HEPATITIS 8 0.0003
536 HYPOXIA 11 0.0003
537 ANOREXIA 4 0.0003
538 UNRESPONSIVE TO STIMULI 8 0.0003
539 PRODUCT AVAILABILITY ISSUE 7 0.0003
540 RENAL FAILURE ACUTE 13 0.0003
541 HYPOGAMMAGLOBULINAEMIA 2 0.0003
542 IMMUNE SYSTEM DISORDER 4 0.0003
543 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
544 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
545 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
546 BODY TEMPERATURE INCREASED 6 0.0003
547 DRUG TOXICITY 4 0.0003
548 CIRCULATORY COLLAPSE 5 0.0003
549 NEUTROPHIL COUNT INCREASED 3 0.0003
550 GINGIVAL BLEEDING 4 0.0003
551 INFARCTION 2 0.0003
552 HELICOBACTER INFECTION 3 0.0003
553 CROHN'S DISEASE 2 0.0003
554 NEPHROTIC SYNDROME 2 0.0003
555 GASTROINTESTINAL DISORDER 26 0.0003
556 EXTRASYSTOLES 2 0.0003
557 OSTEONECROSIS OF JAW 7 0.0003
558 PULMONARY TOXICITY 2 0.0003
559 PLASMA CELL MYELOMA 11 0.0003
560 HYPOKALAEMIA 13 0.0003
561 NEUTROPENIC SEPSIS 2 0.0003
562 SUBDURAL HAEMATOMA 4 0.0003
563 PLEURAL EFFUSION 17 0.0003
564 OEDEMA PERIPHERAL 34 0.0003
565 GASTROENTERITIS VIRAL 5 0.0003
566 OEDEMA 15 0.0003
567 OSTEOMYELITIS 5 0.0003
568 ARRHYTHMIA 13 0.0003
569 GASTROINTESTINAL PAIN 3 0.0003
570 DYSURIA 10 0.0003
571 PSYCHIATRIC SYMPTOM 2 0.0003
572 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
573 RENAL INJURY 8 0.0003
574 HYPOGLYCAEMIA 13 0.0003
575 HAEMORRHAGE INTRACRANIAL 4 0.0003
576 NEPHROPATHY TOXIC 3 0.0003
577 BLOOD SODIUM DECREASED 5 0.0003
578 BLOOD URINE PRESENT 5 0.0003
579 HEPATOCELLULAR CARCINOMA 2 0.0003
580 HAEMATURIA 9 0.0003
581 MYOCARDITIS 3 0.0003
582 GASTRIC HAEMORRHAGE 3 0.0003
583 PHARYNGEAL OEDEMA 4 0.0003
584 ACUTE RESPIRATORY FAILURE 5 0.0003
585 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
586 MUSCULOSKELETAL CHEST PAIN 4 0.0003
587 CELLULITIS 13 0.0003
588 LUNG INFECTION 4 0.0003
589 APNOEA 2 0.0003
590 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
591 DEHYDRATION 34 0.0003
592 CYANOSIS 4 0.0003
593 FURUNCLE 2 0.0003
594 COMA 12 0.0003
595 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
596 PREMATURE DELIVERY 4 0.0003
597 MUSCLE RIGIDITY 3 0.0003
598 MIOSIS 2 0.0002
599 FULL BLOOD COUNT DECREASED 5 0.0002
600 BLOOD POTASSIUM INCREASED 4 0.0002
601 POLYURIA 2 0.0002
602 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
603 OSTEOPOROSIS 10 0.0002
604 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
605 FUNGAL INFECTION 8 0.0002
606 POISONING 3 0.0002
607 DERMATITIS ALLERGIC 3 0.0002
608 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
609 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
610 BRAIN OEDEMA 3 0.0002
611 CANDIDA INFECTION 4 0.0002
612 VOMITING 111 0.0002
613 HEPATIC CYTOLYSIS 3 0.0002
614 ANAPHYLACTIC REACTION 13 0.0002
615 FACIAL PARALYSIS 2 0.0002
616 MYDRIASIS 3 0.0002
617 GASTRIC DISORDER 8 0.0002
618 MUSCULOSKELETAL DISCOMFORT 4 0.0002
619 MUSCLE STRAIN 2 0.0002
620 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
621 NODULE 3 0.0002
622 HYPERKALAEMIA 8 0.0002
623 GROIN PAIN 2 0.0002
624 INTERSTITIAL LUNG DISEASE 11 0.0002
625 ABDOMINAL DISCOMFORT 38 0.0002
626 TACHYCARDIA 20 0.0002
627 EYE HAEMORRHAGE 3 0.0002
628 HEPATOTOXICITY 5 0.0002
629 QUALITY OF LIFE DECREASED 3 0.0002
630 ABDOMINAL PAIN UPPER 46 0.0002
631 GOUT 4 0.0002
632 PNEUMONIA 72 0.0002
633 CHILLS 26 0.0002
634 PULMONARY EMBOLISM 21 0.0002
635 TACHYPNOEA 3 0.0002
636 DISEASE PROGRESSION 26 0.0002
637 HYPOTHYROIDISM 7 0.0002
638 BRAIN NEOPLASM 2 0.0002
639 TINNITUS 10 0.0002
640 NIGHT SWEATS 7 0.0002
641 GRAND MAL CONVULSION 2 0.0002
642 ACUTE KIDNEY INJURY 33 0.0002
643 HEPATIC STEATOSIS 4 0.0002
644 FLANK PAIN 2 0.0002
645 PHOTOPHOBIA 4 0.0002
646 LACERATION 2 0.0002
647 HYPOCALCAEMIA 4 0.0002
648 SINUS TACHYCARDIA 3 0.0002
649 URINARY TRACT INFECTION 36 0.0002
650 BRONCHOSPASM 3 0.0002
651 URINARY RETENTION 7 0.0002
652 HYPOACUSIS 9 0.0002
653 LETHARGY 12 0.0002
654 HYPERTHYROIDISM 3 0.0002
655 HAEMORRHOIDS 4 0.0002
656 LUNG DISORDER 10 0.0002
657 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
658 ANGIOEDEMA 9 0.0002
659 CARDIAC DISORDER 19 0.0002
660 RESPIRATORY DISORDER 6 0.0002
661 HYPOTONIA 2 0.0002
662 SPINAL FRACTURE 4 0.0002
663 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
664 OSTEOPENIA 3 0.0002
665 HAEMATEMESIS 5 0.0002
666 HYPOPHAGIA 5 0.0002
667 INJECTION SITE RASH 6 0.0002
668 CEREBRAL HAEMORRHAGE 7 0.0002
669 ATRIAL FIBRILLATION 19 0.0002
670 VISUAL IMPAIRMENT 24 0.0002
671 SKIN ULCER 5 0.0002
672 PERITONITIS 4 0.0002
673 HYPERBILIRUBINAEMIA 2 0.0002
674 HAEMATOMA 5 0.0002
675 RESPIRATORY TRACT INFECTION 5 0.0002
676 CARDIO-RESPIRATORY ARREST 8 0.0002
677 FOLLICULITIS 2 0.0002
678 INJECTION SITE DISCOMFORT 2 0.0002
679 GASTRITIS 5 0.0002
680 ULCER 3 0.0002
681 DECREASED ACTIVITY 2 0.0002
682 PHARYNGITIS STREPTOCOCCAL 2 0.0002
683 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
684 BACK INJURY 2 0.0002
685 OROPHARYNGEAL PAIN 17 0.0002
686 PULMONARY THROMBOSIS 2 0.0002
687 ASPIRATION 2 0.0002
688 SKIN LESION 5 0.0002
689 VENTRICULAR TACHYCARDIA 3 0.0002
690 PHOTOSENSITIVITY REACTION 3 0.0002
691 RESPIRATORY ARREST 5 0.0002
692 DIARRHOEA 116 0.0002
693 HEMIPARESIS 3 0.0002
694 BRONCHITIS 13 0.0002
695 DERMATITIS CONTACT 2 0.0002
696 CHOLECYSTECTOMY 2 0.0002
697 INJECTION SITE REACTION 12 0.0002
698 PERICARDIAL EFFUSION 4 0.0002
699 POST PROCEDURAL HAEMORRHAGE 2 0.0002
700 OFF LABEL USE 150 0.0002
701 DYSPHONIA 10 0.0002
702 BRADYCARDIA 9 0.0002
703 COVID-19 PNEUMONIA 2 0.0002
704 ISCHAEMIC STROKE 3 0.0002
705 MYOCLONUS 2 0.0002
706 HYPERLIPIDAEMIA 2 0.0002
707 RASH PRURITIC 9 0.0002
708 DYSPNOEA 94 0.0002
709 APHASIA 5 0.0002
710 BLOOD PRESSURE DECREASED 11 0.0002
711 PELVIC PAIN 3 0.0002
712 THERAPEUTIC RESPONSE DECREASED 10 0.0002
713 HYPERGLYCAEMIA 6 0.0002
714 CONDITION AGGRAVATED 50 0.0002
715 NO THERAPEUTIC RESPONSE 2 0.0002
716 CEREBRAL INFARCTION 4 0.0002
717 DRUG ADMINISTRATION ERROR 5 0.0002
718 CARDIOMEGALY 2 0.0002
719 CHEST PAIN 30 0.0002
720 ARTHROPATHY 9 0.0002
721 CONJUNCTIVITIS 3 0.0002
722 INFLUENZA 18 0.0002
723 THINKING ABNORMAL 3 0.0002
724 EPISTAXIS 12 0.0002
725 BLISTER 9 0.0002
726 PNEUMONIA ASPIRATION 4 0.0002
727 DECREASED APPETITE 37 0.0002
728 FEELING JITTERY 3 0.0002
729 CYSTITIS 5 0.0002
730 ASTHENIA 59 0.0002
731 THERAPY NON-RESPONDER 7 0.0002
732 MALAISE 68 0.0002
733 TOXICITY TO VARIOUS AGENTS 26 0.0002
734 WEIGHT DECREASED 43 0.0002
735 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
736 BONE PAIN 9 0.0002
737 MUCOSAL INFLAMMATION 4 0.0002
738 MUSCULOSKELETAL PAIN 8 0.0002
739 SPEECH DISORDER 8 0.0002
740 HAND DEFORMITY 2 0.0002
741 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
742 NEOPLASM MALIGNANT 10 0.0001
743 PREGNANCY 3 0.0001
744 HYPOTENSION 30 0.0001
745 PRODUCT USE ISSUE 28 0.0001
746 STOMATITIS 9 0.0001
747 FEEDING DISORDER 3 0.0001
748 IMPAIRED GASTRIC EMPTYING 2 0.0001
749 SINUSITIS 15 0.0001
750 CORONARY ARTERY OCCLUSION 2 0.0001
751 CONTUSION 14 0.0001
752 FEELING COLD 4 0.0001
753 OXYGEN SATURATION DECREASED 8 0.0001
754 LYMPHADENOPATHY 5 0.0001
755 HEPATOCELLULAR INJURY 2 0.0001
756 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
757 ARTHRITIS 11 0.0001
758 LIVER FUNCTION TEST INCREASED 3 0.0001
759 RECTAL HAEMORRHAGE 6 0.0001
760 PAIN IN EXTREMITY 41 0.0001
761 DEEP VEIN THROMBOSIS 9 0.0001
762 HYPOKINESIA 2 0.0001
763 FLUID OVERLOAD 2 0.0001
764 URTICARIA 23 0.0001
765 PALPITATIONS 16 0.0001
766 MELAENA 3 0.0001
767 ACUTE MYOCARDIAL INFARCTION 4 0.0001
768 RASH MACULO-PAPULAR 3 0.0001
769 HYPERSENSITIVITY 25 0.0001
770 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
771 IMMUNODEFICIENCY 2 0.0001
772 GLOSSODYNIA 3 0.0001
773 RASH PAPULAR 3 0.0001
774 PANCREATITIS ACUTE 3 0.0001
775 BONE LOSS 2 0.0001
776 CONSTIPATION 29 0.0001
777 PANCREATITIS 7 0.0001
778 DYSPEPSIA 13 0.0001
779 COUGH 37 0.0001
780 DISCOMFORT 8 0.0001
781 DRUG DISPENSING ERROR 2 0.0001
782 SHOCK 3 0.0001
783 NAUSEA 102 0.0001
784 SWELLING 12 0.0001
785 NERVOUS SYSTEM DISORDER 4 0.0001
786 ERYTHEMA 26 0.0001
787 OBESITY 2 0.0001
788 WEIGHT INCREASED 28 0.0001
789 BACK PAIN 29 0.0001
790 ABORTION SPONTANEOUS 5 0.0001
791 HAEMORRHAGE 13 0.0001
792 THROMBOSIS 10 0.0001
793 LOCALISED INFECTION 3 0.0001
794 RASH 54 0.0001
795 VISION BLURRED 17 0.0001
796 LACTIC ACIDOSIS 4 0.0001
797 SWELLING FACE 8 0.0001
798 PAIN 75 0.0001
799 FATIGUE 95 0.0001
800 MULTIPLE FRACTURES 2 0.0001
801 DRUG INEFFECTIVE 160 0.0001
802 STAPHYLOCOCCAL INFECTION 4 0.0001
803 CARDIAC ARREST 10 0.0001
804 DRUG LEVEL INCREASED 2 0.0001
805 DEATH 104 0.0001
806 ARTHRALGIA 50 0.0001
807 SYNCOPE 12 0.0001
808 CHRONIC KIDNEY DISEASE 9 0.0001
809 CARDIOVASCULAR DISORDER 3 0.0001
810 INFLAMMATION 6 0.0001
811 EOSINOPHILIA 2 0.0001
812 COVID-19 20 0.0001
813 COLD SWEAT 2 0.0001
814 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
815 INJECTION SITE ERYTHEMA 14 0.0001
816 EAR INFECTION 3 0.0001
817 THROAT TIGHTNESS 3 0.0001
818 MOOD ALTERED 3 0.0001
819 INFLUENZA LIKE ILLNESS 9 0.0001
820 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
821 INTENTIONAL OVERDOSE 7 0.0001
822 SKIN DISCOLOURATION 5 0.0001
823 JOINT SWELLING 13 0.0001
824 HALLUCINATION 8 0.0001
825 INTESTINAL OBSTRUCTION 4 0.0001
826 FLATULENCE 6 0.0001
827 FRACTURE 2 0.0001
828 FOOT FRACTURE 2 0.0001
829 MUSCULOSKELETAL DISORDER 2 0.0001
830 PRODUCTIVE COUGH 5 0.0001
831 INCREASED APPETITE 2 0.0001
832 HERPES ZOSTER 6 0.0001
833 INJECTION SITE SWELLING 8 0.0001
834 PULMONARY FIBROSIS 2 0.0001
835 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
836 POST PROCEDURAL COMPLICATION 2 0.0001
837 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
838 KIDNEY INFECTION 2 0.0001
839 URINARY INCONTINENCE 3 0.0001
840 CATARACT 6 0.0001
841 BURNING SENSATION 7 0.0001
842 CYTOKINE RELEASE SYNDROME 2 0.0001
843 PRURITUS 38 0.0001
844 ILL-DEFINED DISORDER 6 0.0001
845 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
846 INJECTION SITE WARMTH 2 0.0001
847 FEMUR FRACTURE 3 0.0001
848 BLOOD GLUCOSE INCREASED 18 0.0001
849 MOUTH ULCERATION 2 0.0001
850 DYSPHAGIA 9 0.0001
851 CEREBROVASCULAR ACCIDENT 16 0.0001
852 POOR QUALITY SLEEP 2 0.0001
853 HEADACHE 58 0.0001
854 OSTEONECROSIS 3 0.0001
855 PERIPHERAL SWELLING 14 0.0001
856 HAEMATOCHEZIA 5 0.0001
857 EXPIRED PRODUCT ADMINISTERED 3 0.0001
858 LIP SWELLING 3 0.0001
859 GAIT INABILITY 3 0.0001
860 CONVULSION 5 0.0001
861 MUSCLE TWITCHING 2 0.0001
862 ABDOMINAL DISTENSION 9 0.0001
863 LOSS OF CONSCIOUSNESS 11 0.0001
864 HEART RATE DECREASED 3 0.0001
865 PRODUCT PRESCRIBING ERROR 2 0.0001
866 THERAPY INTERRUPTED 6 0.0001
867 RASH ERYTHEMATOUS 4 0.0001
868 GAIT DISTURBANCE 16 0.0001
869 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
870 BLOOD GLUCOSE DECREASED 4 0.0001
871 DIABETIC KETOACIDOSIS 2 0.0001
872 HEPATIC CANCER 2 0.0001
873 CRYING 3 0.0001
874 PRESYNCOPE 2 0.0001
875 ACCIDENTAL OVERDOSE 3 0.0001
876 INJECTION SITE URTICARIA 2 0.0001
877 INJECTION SITE MASS 3 0.0001
878 DYSGEUSIA 6 0.0001
879 EYE SWELLING 3 0.0001
880 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
881 DEPRESSION 18 0.0001
882 FLUID RETENTION 4 0.0001
883 DRUG RESISTANCE 2 0.0001
884 ANAPHYLACTIC SHOCK 2 0.0001
885 RHINORRHOEA 5 0.0001
886 MYALGIA 13 0.0001
887 ECZEMA 4 0.0001
888 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
889 ABNORMAL BEHAVIOUR 3 0.0001
890 HYPERTENSION 16 0.0001
891 FEELING ABNORMAL 18 0.0001
892 PRODUCT DOSE OMISSION ISSUE 22 0.0001
893 FEAR 2 0.0001
894 PAIN OF SKIN 2 0.0001
895 LIMB INJURY 2 0.0001
896 MIGRAINE 7 0.0001
897 MEMORY IMPAIRMENT 10 0.0001
898 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
899 TREATMENT FAILURE 6 0.0001
900 COMPLETED SUICIDE 6 0.0001
901 MEDICATION ERROR 4 0.0001
902 POLLAKIURIA 3 0.0001
903 HAEMOPTYSIS 2 0.0001
904 NECK PAIN 4 0.0001
905 DEMENTIA 2 0.0001
906 MUSCLE SPASMS 13 0.0001
907 HEART RATE INCREASED 7 0.0001
908 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
909 NASOPHARYNGITIS 13 0.0001
910 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
911 INTENTIONAL DOSE OMISSION 2 0.0001
912 ANGINA PECTORIS 2 0.0001
913 HYPERSOMNIA 2 0.0001
914 PANCREATIC CARCINOMA 2 0.0001
915 MUSCULOSKELETAL STIFFNESS 6 0.0001
916 INJECTION SITE PAIN 21 0.0001
917 CHEST DISCOMFORT 7 0.0001
918 NASAL CONGESTION 4 0.0001
919 INSOMNIA 18 0.0001
920 EPILEPSY 2 0.0001
921 EMOTIONAL DISORDER 2 0.0001
922 LIMB DISCOMFORT 2 0.0001
923 SOMNOLENCE 13 0.0001
924 BONE DENSITY DECREASED 2 0.0001
925 FALL 21 0.0001
926 MOVEMENT DISORDER 2 0.0001
927 HIP FRACTURE 2 0.0001
928 CONFUSIONAL STATE 10 0.0001
929 AMNESIA 4 0.0001
930 SEIZURE 7 0.0001
931 INFUSION RELATED REACTION 4 0.0001
932 DIZZINESS 30 0.0001
933 ILLNESS 6 0.0001
934 NIGHTMARE 2 0.0001
935 DELIRIUM 2 0.0001
936 INTENTIONAL PRODUCT MISUSE 5 0.0001
937 DEPRESSED MOOD 3 0.0001
938 DRUG INTERACTION 9 0.0001
939 SLEEP DISORDER 4 0.0001
940 DRUG EFFECT DECREASED 3 0.0001
941 PANIC ATTACK 2 0.0001
942 UNDERDOSE 4 0.0001
943 HYPERHIDROSIS 7 0.0001
944 HYPONATRAEMIA 3 0.0001
945 DYSARTHRIA 2 0.0001
946 MUSCULAR WEAKNESS 6 0.0001
947 COLITIS 2 0.0001
948 DRY SKIN 7 0.0001
949 SURGERY 3 0.0001
950 ALOPECIA 10 0.0001
951 IRRITABILITY 3 0.0000
952 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
953 DRY MOUTH 4 0.0000
954 VERTIGO 3 0.0000
955 TREMOR 8 0.0000
956 HYPOAESTHESIA 7 0.0000
957 PRODUCT STORAGE ERROR 4 0.0000
958 HOSPITALISATION 7 0.0000
959 INJECTION SITE PRURITUS 3 0.0000
960 ADVERSE DRUG REACTION 4 0.0000
961 PARAESTHESIA 7 0.0000
962 RHEUMATOID ARTHRITIS 5 0.0000
963 BLOOD CHOLESTEROL INCREASED 2 0.0000
964 DEVICE MALFUNCTION 3 0.0000
965 NEUROPATHY PERIPHERAL 4 0.0000
966 DISEASE RECURRENCE 2 0.0000
967 AGITATION 3 0.0000
968 MYOCARDIAL INFARCTION 7 0.0000
969 DRY EYE 2 0.0000
970 AGGRESSION 2 0.0000
971 UNEVALUABLE EVENT 3 0.0000
972 FLUSHING 4 0.0000
973 ANXIETY 11 0.0000
974 NERVOUSNESS 2 0.0000
975 DISTURBANCE IN ATTENTION 2 0.0000
976 OVERDOSE 8 0.0000
977 EYE PAIN 2 0.0000
978 ASTHMA 4 0.0000
979 EYE IRRITATION 2 0.0000
980 BALANCE DISORDER 3 0.0000
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
982 BLOOD PRESSURE INCREASED 5 0.0000
983 FEELING HOT 2 0.0000
984 INCORRECT DOSE ADMINISTERED 7 0.0000
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
986 PRODUCT QUALITY ISSUE 4 0.0000
987 MOBILITY DECREASED 2 0.0000
988 HOT FLUSH 2 0.0000
989 INJECTION SITE HAEMORRHAGE 2 0.0000
990 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
991 DRUG WITHDRAWAL SYNDROME 2 0.0000
992 ADVERSE EVENT 2 0.0000
993 DRUG DOSE OMISSION 3 0.0000
994 EMOTIONAL DISTRESS 2 0.0000
995 NO ADVERSE EVENT 2 0.0000